Ascendis Pharma A/S New Provisions Other Provisions
Ascendis Pharma A/S (ASND) reported New Provisions Other Provisions of EUR 74.29 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:NewProvisionsOtherProvisions · last filed 2026-02-11
| Period end | New Provisions Other Provisions 12 month |
|---|---|
| 2025-12-31 | 74.29M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 57.28M EUR 20-F · filed 2025-02-12 |